St. John's Wort (Hypericum perforatum L.) Old and New

被引:0
|
作者
Keusgen, Michael [1 ]
机构
[1] Philipps Univ Marburg, Dekanat Pharm, Wilhelm Roser Str 2, D-35032 Marburg, Germany
来源
关键词
Hypericum. chemical composition; neurodegenerative diseases; Rotel; breeding;
D O I
暂无
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
St. John's wort (Hypericum perforatum L) is a species that is widespread in Europe and belongs to the family of St. John's wort (Hypericaceae). There are around 450 species of Hypericum worldwide, with shrubs and trees occurring alongside herbaceous plants. In addition to H. perforatum, the species H. scabrum L and H. sampsonii Hance are used in Asia, the latter being a component of traditional Chinese medicine (TCM). H. perforatum has been monographed in European pharmacopoeias for many years and can be described as a typical flavonoid drug. In addition to numerous flavonoids, there are also many other substances that can be assigned to the naphthodianthrones such as hypericin, hyperforins, xanthones and essential oil substances. For this reason, medicinal plant breeding in recent decades has been based on the guidelines of the pharmacopoeia. In recent times, however, scientific evidence has increased that H. perforatum extracts can indeed be used to treat dementia, especially Alzheimer's disease. It seems that hyperforin and hypericin are not the only substances that determine the value. If H. perfora Cum were to prevail in the treatment of dementia and Alzheimer's disease, significant breeding efforts would be necessary to enrich the components that are effective in treating dementia. Finally, it must be mentioned that the Hypericum species listed above are used to treat a variety of other diseases, such as digestive problems and skin diseases.
引用
收藏
页码:52 / 56
页数:5
相关论文
共 50 条
  • [21] Leaf explant response in in vitro culture of St. John's wort (Hypericum perforatum L.)
    Wojcik, Anna
    Podstolski, Andrzej
    [J]. ACTA PHYSIOLOGIAE PLANTARUM, 2007, 29 (02) : 151 - 156
  • [22] Adverse effects profile of the herbal antidepressant St. John's wort (Hypericum perforatum L.)
    Ernst, E
    Rand, JI
    Barnes, J
    Stevinson, C
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 54 (08) : 589 - 594
  • [23] In vitro production and chemical characterization of St. John's wort (Hypericum perforatum L. cv 'New Stem')
    Zobayed, SMA
    Murch, SJ
    Rupasinghe, HPV
    Saxena, PK
    [J]. PLANT SCIENCE, 2004, 166 (02) : 333 - 340
  • [24] St John's wort (Hypericum perforatum)
    Barnes, Joanne
    [J]. JOURNAL OF PRIMARY HEALTH CARE, 2009, 1 (01) : 65 - 65
  • [25] The experimental and clinical pharmacology of St John's wort (Hypericum perforatum L.)
    Nathan, PJ
    [J]. MOLECULAR PSYCHIATRY, 1999, 4 (04) : 333 - 338
  • [26] The experimental and clinical pharmacology of St John's Wort (Hypericum perforatum L.)
    P J Nathan
    [J]. Molecular Psychiatry, 1999, 4 : 333 - 338
  • [27] Effects of St John's Wort (Hypericum perforatum L.) Extracts on Epileptogenesis
    Ivetic, Vesna
    Trivic, Svetlana
    Pogancev, Marija Knezevic
    Popovic, Mira
    Zlinska, Janka
    [J]. MOLECULES, 2011, 16 (09): : 8062 - 8075
  • [28] St. John's wort (Hypericum perforatum L.):: Challenges and strategies for production of chemically consistent plants
    Murch, Susan J.
    Saxena, Praveen K.
    [J]. CANADIAN JOURNAL OF PLANT SCIENCE, 2006, 86 (03) : 765 - 771
  • [29] Characteristics of plant communities containing St. John's wort (Hypericum perforatum L.) in the Saratov Region
    Parkhomenko, V. M.
    Kashin, A. S.
    [J]. BIOLOGY BULLETIN, 2011, 38 (10) : 1023 - 1030
  • [30] Composition and antioxidant activity in vitro of different St. John's Wort (Hypericum perforatum L.) extracts
    Franchi, Gian Gabriele
    Nencini, Cristina
    Collavoli, Elga
    Massarelli, Paola
    [J]. JOURNAL OF MEDICINAL PLANTS RESEARCH, 2011, 5 (17): : 4349 - 4353